Pilot Study: Incorporation of Pharmacogenetic Testing in Medication Therapy Management Services

References

• Prescription drug use in the past 30 days by sex, age, race, and Hispanic origin: United States, selected years 1988–1944 through 2005–2008 . In : Health, United States, 2011: With Special Feature on Socioeconomic Status and Health, Statistics NCFH . US Government Printing Office , MD, USA ( 2012 ).
   Google Scholar
• US Centers for Disease Control and Prevention/National Center for Health Statistics . Health, United States, 2012 . www.cdc.gov/nchs/data/hus/hus12.pdf .
   Google Scholar
• Haga SB , MoaddebJ . Comparison of delivery strategies for pharmacogenetic testing services . Pharmacogenet. Genomics24 ( 3 ), 139 – 145 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Pellegrino AN , MartinMT , TiltonJJ , TouchetteDR . Medication therapy management services: definitions and outcomes . Drugs69 ( 4 ), 393 – 406 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ramalho De Oliveira D , BrummelAR , MillerDB . Medication therapy management: 10 years of experience in a large integrated health care system . J. Manag. Care Pharm.16 ( 3 ), 185 – 195 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Barnett MJ , FrankJ , WehringHet al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years . J. Manag. Care Pharm.15 ( 1 ), 18 – 31 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gervasini G , BenitezJ , CarrilloJA . Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy . Eur. J Clin. Pharmacol.66 ( 8 ), 755 – 774 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Relling MV , KleinTE . CPIC. Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network . Clin. Pharmacol. Ther.89 ( 3 ), 464 – 467 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Reiss SM . Integrating pharmacogenomics into pharmacy practice via medication therapy management . J. Am. Pharm. Assoc.51 ( 6 ), e64 – e74 ( 2011 ).
   Google Scholar
• Shaw L , BurckhardG . Therapeutic drug monitoring and pharmacogenetics interface considerations. Laboratory medicine practice guidelines: guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice . 29 – 34 ( 2010 ). www.guideline.gov/content.aspx?id=15665 .
   Google Scholar
• Hughes CA , GuirguisLM , WongT , NgK , IngL , FisherK . Influence of pharmacy practice on community pharmacists’ integration of medication and lab value information from electronic health records . J. Am. Pharm. Assoc.51 ( 5 ), 591 – 598 ( 2011 ).
   Google Scholar
• Crews KR , CrossSJ , McCormickJNet al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service . Am. J. Health Syst. Pharm.68 ( 2 ), 143 – 150 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Padgett L , O’ConnorS , RoedererM , McLeodH , FerreriS . Pharmacogenomics in a community pharmacy: ACT now . J. Am. Pharm. Assoc.51 ( 2 ), 189 – 193 ( 2011 ).
   Google Scholar
• Swen JJ , Van Der StraatenT , WesselsJAet al. Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19 . Eur. J. Clin. Pharmacol.68 ( 4 ), 363 – 370 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• American Pharmacists Association, National Association of Chain Drug Stores Foundation . Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0) . J. Am. Pharm. Assoc.48 ( 3 ), 341 – 353 ( 2008 ).
   Google Scholar
• Lexicomp . https://online.lexi.com .
   Google Scholar
• PharmGKB . www.pharmgkb.org .
   Google Scholar
• Wilke RA , RamseyLB , JohnsonSGet al. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy . Clin. Pharmacol. Ther.92 ( 1 ), 112 – 117 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Scott SA , SangkuhlK , SteinCMet al. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update . Clin. Pharmacol. Ther.94 ( 3 ), 317 – 323 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hicks JK , SwenJJ , ThornCFet al. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants . Clin. Pharmacol. Ther.93 ( 5 ), 402 – 408 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Johnson JA , GongL , Whirl-CarrilloMet al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing . Clin. Pharmacol. Ther.90 ( 4 ), 625 – 629 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Micromedex . www.micromedex.com .
   Google Scholar
• Kimmel SE , FrenchB , KasnerSEet al. A pharmacogenetic versus a clinical algorithm for warfarin dosing . N. Engl. J. Med.369 ( 24 ), 2283 – 2293 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pirmohamed M , BurnsideG , ErikssonNet al. A randomized trial of genotype-guided dosing of warfarin . N. Engl. J. Med.369 ( 24 ), 2294 – 2303 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Burmester JK , SedovaM , ShaperoMH , MansfieldE . DMET microarray technology for pharmacogenomics-based personalized medicine . Methods Mol. Biol.632 , 99 – 124 ( 2010 ).
   PubMedGoogle Scholar
• Fernandez CA , SmithC , YangWet al. Concordance of DMET plus genotyping results with those of orthogonal genotyping methods . Clin. Pharmacol. Ther.92 ( 3 ), 360 – 365 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. CPIC Pairs . www.pharmgkb.org/cpic/pairs .
   Google Scholar
• Affymetrix product technical notes . www.affymetrix.com/catalog/131412/AFFY/DMET-Plus-Solution#1_3 .
   Google Scholar
• Affymetrix White Paper: DMET™ Plus allele translation reports: Summary of comprehensive drug disposition genotyping into commonly recognized allele names. April 2012 . http://media.affymetrix.com/support/technical/whitepapers/dmet_plus_translation.pdf .
   Google Scholar
• Oetjens MT , DennyJC , RitchieMDet al. Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records . Pharmacogenomics14 ( 7 ), 735 – 744 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Morisky DE , GreenLW , LevineDM . Concurrent and predictive validity of a self-reported measure of medication adherence . Med. Care24 ( 1 ), 67 – 74 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Svarstad BL , ChewningBA , SleathBL , ClaessonC . The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence . Patient Educ. Couns.37 ( 2 ), 113 – 124 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Lapointe NMA , OuFS , CalvertSBet al. Changes in beliefs about medications during long-term care for ischemic heart disease . Am. Heart J.159 ( 4 ), 561 – 569 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lapointe NMA , OuFS , CalvertSBet al. Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome . Am. Heart J.161 ( 5 ), 855 – 863 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Christensen DB , RothM , TrygstadT , ByrdJ . Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan . J. Am. Pharm. Assoc.47 ( 4 ), 471 – 483 ( 2007 ).
   Google Scholar
• Henry TM , SmithS , HichoM . Treat to goal: impact of clinical pharmacist referral service primarily in diabetes management . Hosp. Pharm.48 ( 8 ), 656 – 661 ( 2013 ).
   PubMedGoogle Scholar
• Leveque D , DelpeuchA , GourieuxB . New anticancer agents: role of clinical pharmacy services . Anticancer Res.34 ( 4 ), 1573 – 1578 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tan EC , StewartK , ElliottRA , GeorgeJ . Pharmacist services provided in general practice clinics: a systematic review and meta-analysis . Res. Social Adm. Pharm.10 ( 4 ), 608 – 622 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Drozda K , LabinovY , JiangRet al. A pharmacogenetics service experience for pharmacy students, residents, and fellows . Am. J. Pharm. Educ.77 ( 8 ), 175 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Krynetskiy E , Lee CalligaroI . Introducing pharmacy students to pharmacogenomic analysis . Am. J. Pharm. Educ.73 ( 4 ), 71 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hoffman JM , HaidarCE , WilkinsonMRet al. PG4KDS. A model for the clinical implementation of pre-emptive pharmacogenetics . Am. J. Med. Genet. Part C, Semin. Med. Genet.166 ( 1 ), 45 – 55 ( 2014 ).
   Web of Science ®Google Scholar
• Shuldiner AR , PalmerK , PakyzREet al. Implementation of pharmacogenetics: The University of Maryland personalized anti-platelet pharmacogenetics program . Am. J. Med. Genet. Part C, Semin. Med. Genet.166 ( 1 ), 76 – 84 ( 2014 ).
   Web of Science ®Google Scholar